Skip to main content

Stent drug-eluting clopidogrel

CBE ID
0588
1.4 Project
Cardiovascular
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Full Year 2013
Is Under Review
No
1.3 Measure Description

This measure identifies patients undergoing percutaneous coronary intervention (PCI) with placement of a drug-eluting intracoronary stent during the first 9 months of the measurement year, who filled a prescription for clopidogrel in the 3 months following stent placement.

    • 1.14 Numerator

      Patients in the denominator who filled prescription(s) for clopidogrel in the 3 months following placement of the drug-eluting intracoronary stent. ("Evidence suggests clopidogrel should be continued upwards of 1 year.")

      Time Window: 3 months after stent placement

    • 1.15 Denominator

      Patients who underwent PCI with placement of a drug-eluting intracoronary stent, during the first 9 months of the measurement year, excluding those with contraindications to clopidogrel

    • Exclusions

      contraindications to clopidogrel

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Cardiovascular Project 2013-2014
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      Resolution Health, Inc.
      Steward Organization POC Email
      [email protected]